Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC)

1.35
Delayed Data
As of 3:59pm ET
 -0.0904 / -6.28%
Today’s Change
1.28
Today|||52-Week Range
6.15
-22.44%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Revenue and IncomeNet Revenues1.7M1.9M843.0K0.00
 
 
 
 
Depreciation And Amortization174.0K210.0K133.0K32.0K
 
 
 
 
 
 
Operating ExpensesGross Income-------32.0K
 
 
General Expenses24.0M17.9M14.9M9.5M
 
 
 
 
 
Research And Development18.1M12.2M9.3M4.2M
 
 
 
 
 
Total Operating Expenses24.2M18.1M15.0M9.5M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-22.4M-16.2M-14.2M-9.5M
 
 
 
 
 
Extraordinary Charge-322.0K-51.0K0.000.00
 
 
 
Other Expenses104.0K-274.0K339.0K910.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-22.6M-16.5M-13.8M-8.5M
 
 
 
 
 
Income Taxes-3.2M-2.1M-2.0M-993.0K
 
 
 
 
 
Preferred Dividend-200.0K-201.0K-200.0K-7.4M
 
 
 
 
 
Discontinued Operations19.0K0.000.000.00
 
 
Net Income-19.4M-14.3M-11.8M-7.5M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS1.8M2.7M3.4M7.6M
 
 
 
 
 
Shares To Calculate EPS Diluted1.8M2.7M3.4M7.6M
 
 
 
 
 
 
Earnings Per ShareEPS-$10.68-$5.40-$3.50-$1.95
 
 
 
 
 
EPS Diluted-$10.68-$5.40-$3.50-$1.95